Dear Dr. Kass:

Please do not spread here Dr. Xiao's lies that he told you and your Beaumont team.

You said:
"Mr Fang, on the other hand, is an individual who is reported to have published research that was not his, and was reportedly called on it by Dr Xiao."

Please give your reference to Dr. Fang's "published research that was not his". If you meant to Xiao's false plagiarism accusation to Science Magazine agaist Fang's popular science writing that introduces scientific advances (one of which published in Science), please read the response from Science, at the bottom portion of this post (note: Fang's writing is not a research paper nor a journalistic article):
http://www.xys.org/xys/netters/Fang-Zhouzi/Net/zhaojijun2.txt

You said:
"He (Xiao) has not tried to hide any of his research results or any other information."

We would like to expose here one lie that was told by Xiao, and then you Beaumont Hospital propagated the lie to entice patients:

http://xysblogs.org/wp-content/blogs/107/uploads/xpletter.html#l10
Beaumont repeatedly provided false information that the procedure is "now standard of care" in China and is "done everyday in hospitals in China".

Another lie, how an official document testifying the "85% success rate" was fabricated:
http://xysblogs.org/wp-content/blogs/107/uploads/xpletter.html#l4

Now, please allow us ask you one question:
As a member of Beaumont team who have conducted the priliminary trial and obtained the NIH fund for the Xiao Procedure, anyone of your team has ever read this conference report that claims more than 85% success rate on which your trials are mainly based:

Xiao CG. A somatic-autonomic reflex pathway procedure for neurogenic bladder and bowel: results on 92 patients with SCI and 110 children with spina bifida. . In: Proceedings of the International Conference of Urology; Shanghai, July 2-4, Shanghai, China; 2005.

Hint: this important conference report is in fact non-existent in the literature.
http://xysblogs.org/wp-content/blogs/107/uploads/xpletter.html#l8

Message awaits moderator approval